Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: 'Multiple myeloma' and a link to MedlinePlus Genetics.SummaryDifference0.1%

- Check14 days agoChange DetectedThe study page now shows recruitment status and adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), with the Revision reference updated to v3.6.0. The Intervention/Treatment heading is standardized by replacing 'Intervention / Treatment' with 'Intervention/Treatment' and the older 'Revision: v3.5.5' label is removed.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now includes a related topics block with Multiple myeloma and MedlinePlus Genetics and shows Revision: v3.5.5, replacing Revision: v3.5.4.SummaryDifference0.2%

- Check35 days agoChange DetectedEntries under the related topics section have been removed: 'Multiple myeloma', the 'related topics:' label, and 'MedlinePlus Genetics'. This reduces the list of related topics displayed on the page.SummaryDifference0.1%

- Check42 days agoChange DetectedNew topic tagging adds 'Multiple myeloma' as a related topic with MedlinePlus Genetics, enhancing cross-references; the revision tag updates from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page revision is updated from v3.5.2 to v3.5.3, indicating a minor metadata update. There are no apparent changes to the study details or visible content.SummaryDifference0.0%

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.